Consistent with previous MYH9-RD cohorts, the phenotype observed in our patients was predominantly hematological, with mild-to-moderate thrombocytopenia and macro-thrombocytes, without any documented life-threatening hemorrhagic events [5,6,8]. This evidence concerns the gene MYH9 and Thrombocytopenia.